Beginning November 1, 2015, DSCSA requires dispensers to track and receive lot-level documentation on every product they purchase and this transactional product documentation must be retained for six years. The original enforcement date was July 1, 2015.

The Centers for Medicare & Medicaid Services (CMS) has announced the bidding timeline for Round 1 2017 of the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program.

The Food and Drug Administration (FDA) does not intend to take action against dispensers who, prior to November 1, 2015, accept ownership of product without receiving the product tracing information.

The Drug Supply Chain Security Act (DSCSA), which is Title II of the Drug Quality and Security Act (DQSA), mandates a full supply chain traceability system from pharmaceutical manufacturer to pharmacy dispenser for prescription drugs being distributed in the United States. Beginning July 1, 2015, DSCSA requires dispensers to track receive lot-level documentation on every product they purchase, including: 1. Transaction History (TH); 2. Transaction Information (TI); and, 3. Transaction Statement (TS). This information will be supplied by drug wholesalers and manufacturers. You must retain transactional product documentation for six years.

Beginning July 1, 2015, DSCSA requires dispensers to track receive lot-level documentation on every product they purchase, including: 1. Transaction History (TH); 2. Transaction Information (TI); and, 3. Transaction Statement (TS). This information will be supplied by drug wholesalers and manufacturers. You must retain transactional product documentation for six years.

The pharmacy industry continues to see consolidation in the prescription drug management business. This week UnitedHealth Group agreed to buy Catamaran Corp in a deal worth approximately $12.8 billion.